Search

Search results

4467 results found

Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial.

Yoosuf, Shakira, Caitlin G Barrett, Konstantinos Papamichael, Sarah E Madoff, Satya Kurada, Joshua Hansen, Jocelyn A Silvester, et al. 2022. “Pancreatic Enzyme Supplementation versus Placebo for Improvement of Gastrointestinal Symptoms in Non-Responsive Celiac Disease: A Cross-over Randomized Controlled Trial.”. Frontiers in Medicine 9: 1001879.

Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.

Yarur, Andres J, Dermot McGovern, Maria T Abreu, Adam Cheifetz, Konstantinos Papamichail, Parakkal Deepak, Alexandra Bruss, et al. 2023. “Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2908-2917.e10.

Glucagon-like Peptide-1 Receptor Agonists Are Associated With a Lower Risk of Peptic Ulcer Disease: A Nationwide Cohort Study.

Seika, Philippa, Jocelyn Chang, Su Min Hong, Sarah Ballou, Vikram Rangan, Chethan Ramprasad, Johanna Iturrino, et al. 2025. “Glucagon-Like Peptide-1 Receptor Agonists Are Associated With a Lower Risk of Peptic Ulcer Disease: A Nationwide Cohort Study.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association.

Nathan Rothschild

Nathan Rothschild is a Clinical Research Student at the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center. He is pursuing a Bachelor of Science in Honours Biochemistry at McGill University. At BIDMC, Nathan contributes to both prospective and retrospective clinical...

Sarah N. Flier, M.D.

Dr. Flier is an Assistant Professor of Medicine at Harvard Medical School and staff physician in the Center for Inflammatory Bowel Diseases at Beth Israel Deaconess Medical Center (BIDMC). Within IBD, she has a particular interest in patients transitioning from pediatric to adult GI providers. This...